Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Cua

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Open Forum Infectious Diseases|August 5, 2024
Prevalence and Risk Factors of Cytomegalovirus Among Men Having Sex With Men Enrolled in a Pre-Exposure Prophylaxis StudySylvain Chawki, Nicolas Leturque, Marine Minier, et al.
Frontiers in Medicine|April 30, 2025
Immunosenescence markers in T- and NK-cells according to the CD4/CD8 ratio in successfully treated people living with HIVMatteo Vassallo, Jacques Durant, Sami Addou, et al.
Journal of the International AIDS Society|February 23, 2020
Changes in kidney function among men having sex with men starting on demand tenofovir disoproxil fumarate - emtricitabine for HIV pre-exposure prophylaxisGeoffroy Liegeon, Guillemette Antoni, Gilles Pialoux, et al.
AIDS Care|June 1, 2018
The ANRS-Ipergay trial, an opportunity to use qualitative research to understand the perception of the "participant"-physician relationshipMarion Di Ciaccio, Christel Protiere, Daniela Rojas Castro, et al.
Plos One|January 6, 2017
COPD in HIV-Infected Patients: CD4 Cell Count Highly CorrelatedKarine Risso, Francine Guillouet-de-Salvador, Laure Valerio, et al.
Open Forum Infectious Diseases|April 2, 2021
Inflammatory Markers During Early Treatment of Seroconverters in a Randomized Placebo-Controlled Trial of PrEP (ANRS-IPERGAY)Sylvain Chawki, Isabelle Charreau, Audrey Gabassi, et al.
HIV Medicine|August 9, 2022
Missed opportunities for HIV pre-exposure prophylaxis among people with recent HIV infection: The French ANRS 95041 OMaPrEP studyCaroline Lions, Helene Laroche, Marion Mora, et al.
Psychology, Health & Medicine|July 12, 2019
Becoming adherent to a preventive treatment for HIV: a qualitative approachCostanza Puppo, Xavier Mabire, Stéphane Morel, et al.
AIDS and Behavior|May 1, 2020
Coverage of Sex Acts by Event-Driven Pre-exposure Prophylaxis: A Sub-Study of the ANRS IPERGAY TrialRebecca Bauer, Emmanuelle Netzer, Claire Pintado, et al.
Sexually Transmitted Infections|October 19, 2021
Risk factors for HIV infection among men who have sex with men in the ANRS IPERGAY PrEP trialJulien Gras, Marine Pillet, Guillemette Antoni, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Open Forum Infectious Diseases|August 5, 2024
Prevalence and Risk Factors of Cytomegalovirus Among Men Having Sex With Men Enrolled in a Pre-Exposure Prophylaxis StudySylvain Chawki, Nicolas Leturque, Marine Minier, et al.
Frontiers in Medicine|April 30, 2025
Immunosenescence markers in T- and NK-cells according to the CD4/CD8 ratio in successfully treated people living with HIVMatteo Vassallo, Jacques Durant, Sami Addou, et al.
Journal of the International AIDS Society|February 23, 2020
Changes in kidney function among men having sex with men starting on demand tenofovir disoproxil fumarate - emtricitabine for HIV pre-exposure prophylaxisGeoffroy Liegeon, Guillemette Antoni, Gilles Pialoux, et al.
AIDS Care|June 1, 2018
The ANRS-Ipergay trial, an opportunity to use qualitative research to understand the perception of the "participant"-physician relationshipMarion Di Ciaccio, Christel Protiere, Daniela Rojas Castro, et al.
Plos One|January 6, 2017
COPD in HIV-Infected Patients: CD4 Cell Count Highly CorrelatedKarine Risso, Francine Guillouet-de-Salvador, Laure Valerio, et al.
Open Forum Infectious Diseases|April 2, 2021
Inflammatory Markers During Early Treatment of Seroconverters in a Randomized Placebo-Controlled Trial of PrEP (ANRS-IPERGAY)Sylvain Chawki, Isabelle Charreau, Audrey Gabassi, et al.
HIV Medicine|August 9, 2022
Missed opportunities for HIV pre-exposure prophylaxis among people with recent HIV infection: The French ANRS 95041 OMaPrEP studyCaroline Lions, Helene Laroche, Marion Mora, et al.
Psychology, Health & Medicine|July 12, 2019
Becoming adherent to a preventive treatment for HIV: a qualitative approachCostanza Puppo, Xavier Mabire, Stéphane Morel, et al.
AIDS and Behavior|May 1, 2020
Coverage of Sex Acts by Event-Driven Pre-exposure Prophylaxis: A Sub-Study of the ANRS IPERGAY TrialRebecca Bauer, Emmanuelle Netzer, Claire Pintado, et al.
Sexually Transmitted Infections|October 19, 2021
Risk factors for HIV infection among men who have sex with men in the ANRS IPERGAY PrEP trialJulien Gras, Marine Pillet, Guillemette Antoni, et al.
Pageof 5